Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic changes after dexmedetomidine vs midazolam in hypertensive patients under anesthesia
IRCT20160202026328N6Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hypertension (HTN) comparing Dexmedetomidine with Midazolam (2 arms). Primary endpoint: Hemodynamic changes. Started Nov 2020; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20160202026328N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160202026328N6.